Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/2004
01/29/2004WO2004008824A2 Genes differentially expressed in breast cancer
01/29/2004WO2003104792A3 Method and system for multi-stage isoelectric focussing
01/29/2004WO2003095485A3 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
01/29/2004WO2003090664A3 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process
01/29/2004WO2003087357A3 Nucleic acid comprising retinal-specific regulatory region
01/29/2004WO2003085098A3 Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti
01/29/2004WO2003080654B1 Helicobacter flagellar, motility polypeptides
01/29/2004WO2003074554A3 Apoptogenic-bacteriocins combining broad spectrum antibiotic and selective anti-tumoral activities, and compositions and uses thereof
01/29/2004WO2003072018A3 Ricin vaccine and methods of making and using thereof
01/29/2004WO2003059932A3 Methods of inducing or enhancing connective tissue repair
01/29/2004WO2003054207A3 Fermentation process for the preparation of l-amino acids using coryneform bacteria
01/29/2004WO2003048775A3 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
01/29/2004WO2003048184A3 Flavivirus ns1 subunit vaccine
01/29/2004WO2003044173A3 Antitumor activity of bok
01/29/2004WO2003038113A3 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
01/29/2004WO2003028654A3 Storage-stable human fibrinogen solutions
01/29/2004WO2003020953A3 Compositions and methods relating to colon specific genes and proteins
01/29/2004WO2003020111A3 Alternatively spliced circulating tissue factor
01/29/2004WO2003017944A3 Gpi-anchored cytokines
01/29/2004WO2003016562A3 Compositions and methods for detecting multidrug resistant strains of m. tuberculosis having mutations in genes of the mutt family
01/29/2004WO2003002137A3 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis
01/29/2004WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use
01/29/2004WO2002095001A3 Btf3: an inhibitor of apoptosis
01/29/2004WO2002088377A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
01/29/2004WO2002083900A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
01/29/2004WO2002078635A3 Estrogen receptor modulators
01/29/2004WO2002078631A3 Improved conditionally replicating vectors for inhibiting viral infections
01/29/2004WO2002077036A3 Recombinant production of polyanionic polymers, and uses thereof
01/29/2004WO2002072794A3 Immunoglobulin superfamily proteins
01/29/2004WO2002068652A3 Nov-x proteins and nucleic acids encoding same
01/29/2004WO2002066615A9 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
01/29/2004WO2002063307A3 Methods of assessing wolframin protein activity
01/29/2004WO2000063417A8 Proteins that regulate systemic acquired resistance in plants
01/29/2004US20040019935 Gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene
01/29/2004US20040019934 Root-specific conifer gene promoter and its use
01/29/2004US20040019933 An isolated polynucleotide encoding a PtM3 or its homolog PtM4 polypeptide; producing a transgenic plant that exhibits altered characteristics resulting from over expression or under expression of above polypeptide
01/29/2004US20040019928 Nucleic acids that encode reverse transcriptases
01/29/2004US20040019927 Polynucleotides and polypeptides in plants
01/29/2004US20040019926 Novel plant cyclin-dependent kinase inhibitors
01/29/2004US20040019925 Biochemistry-related polynucleotides and polypeptides in plants
01/29/2004US20040019921 Non-human mammal with disrupted or modified MIF gene, and uses thereof
01/29/2004US20040019920 Transgenic animals
01/29/2004US20040019919 Calsyntenin-1-3 proteins, predominantly expressed in the nervous system , useful for the screening and for the preparation of a medicament for the treatment of nervous system disorders, most preferably brain
01/29/2004US20040019917 NEOKINE protein and nucleic acid molecules and uses therefor
01/29/2004US20040019916 In vivo homologous sequence targeting in eukaryotic cells
01/29/2004US20040019915 Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
01/29/2004US20040019195 Foreign nucleic acid molecule encoding multiple costimulatory molecules, such as B7-1 or B7-2 (antigents), intercellular adhesion molecules and leukocyte function associated antigen-3
01/29/2004US20040019194 Ixodes salivary anticomplement protein
01/29/2004US20040019193 Contacting a sample from the patient with an antibody to Mob-5; and detecting the binding of the antibody with antigen in the sample, wherein binding indicates the presence of Mob-5 antigen sample, an indicator of cancer
01/29/2004US20040019189 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
01/29/2004US20040019186 Complex of lecithin and sugar; immobilization; washing; liquid removal; recovering
01/29/2004US20040019185 Process for preparing purified active monomer of bone-derived factor
01/29/2004US20040019183 Genetic engineering; binding to antibody
01/29/2004US20040019182 Reagents and methods for assaying Bacillus anthracis lethal factor protease
01/29/2004US20040019181 Antimicrobial cationic peptides
01/29/2004US20040019006 Diagnosis, analyzing neuropathic pain; genetic engineered polypeptides
01/29/2004US20040019004 Anticancer agents; antitumor agents
01/29/2004US20040018982 Nematicidal proteins
01/29/2004US20040018981 Glucagon-like peptide-1 (glp-1) receptor agonist
01/29/2004US20040018980 Novel FIZZ proteins
01/29/2004US20040018979 Anticholesterol agents
01/29/2004US20040018976 Polypeptide for diagnosis, therapy
01/29/2004US20040018975 Glucagon-like peptides; reducing body weight
01/29/2004US20040018973 Diagnosis cell proliferation; binding antibody to nucleic acids
01/29/2004US20040018971 Anticancer agents; vaccine
01/29/2004US20040018970 Novel nucleic acids and polypeptides and methods of use thereof
01/29/2004US20040018969 Genetic engineering; central nervous system disorders
01/29/2004US20040018967 Ligand/lytic peptide compositions and methods of use
01/29/2004US20040018957 Screening ligands which modulation interaction; antiproliferative agents
01/29/2004US20040018639 Using extract from mammal thymus glands; analyzing precipitation patterns
01/29/2004US20040018627 High-efficiency AAV helper functions
01/29/2004US20040018625 Inducible methods for repressing gene function
01/29/2004US20040018619 Central nervous system disorders; psychological disorders; therapy for brain tumors
01/29/2004US20040018618 Genetic engineering; hybrid proteins; gene expression; human gene therapy
01/29/2004US20040018606 Control of protein systemic delivery by hypoxia using a tet-HIF1-alpha chimeric transactivator
01/29/2004US20040018603 Checkpoint-activating oligonucleotides
01/29/2004US20040018601 Sequestering, accumulation; immobilized lipid
01/29/2004US20040018596 Process for producing polypeptide having disulfide bond
01/29/2004US20040018595 Production of recombinant bmp-2
01/29/2004US20040018594 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
01/29/2004US20040018592 Purity; genetic engineering
01/29/2004US20040018591 Methods and compositions for protein expression and purification
01/29/2004US20040018589 Induce immunology response; in situ proteolysis
01/29/2004US20040018586 Method for refolding proteins containing free cysteine residues
01/29/2004US20040018574 Molecular differences between species of the M. tuberculosis complex
01/29/2004US20040018572 Mutant Plk protein and gene encoding the same
01/29/2004US20040018571 PSCA: prostate stem cell antigen and uses thereof
01/29/2004US20040018569 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
01/29/2004US20040018567 Proteins; antiproliferative agent; autoimmune disease; antiinflammatory agents
01/29/2004US20040018566 Modulators of leukocyte activation, BIC compositions and methods of use
01/29/2004US20040018562 Enzyme as membrane receptor; determining binding
01/29/2004US20040018561 Peptide compounds and their use as protease substrates
01/29/2004US20040018560 Crystallized LXR polypeptide in complex with a ligand and screening methods employing same
01/29/2004US20040018558 Method for identifying modulators of G protein coupled receptor signaling
01/29/2004US20040018555 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
01/29/2004US20040018553 Reagents and methods useful for detecting diseases of the prostate
01/29/2004US20040018549 Antiinflammatory agents; induction immunology response; binding to antibody
01/29/2004US20040018547 Ion channel receptor and uses thereof
01/29/2004US20040018544 Nucleic acid bonding to tumor necrosis factor; genetic engineering; culture product
01/29/2004US20040018537 Genes for detecting bacteria and a method for detecting bacteria by using the genes